Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Consolidated Net Income: 2010-2018

Historic Consolidated Net Income for EyePoint Pharmaceuticals (EYPT) over the last 9 years, with Jun 2018 value amounting to -$53.2 million.

  • EyePoint Pharmaceuticals' Consolidated Net Income fell 139.24% to -$14.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$34.6 million, marking a year-over-year decrease of 99.88%. This contributed to the annual value of -$53.2 million for FY2018, which is 187.64% down from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its Consolidated Net Income stood at -$53.2 million for FY2018, which was down 187.64% from -$18.5 million recorded in FY2017.
  • EyePoint Pharmaceuticals' 5-year Consolidated Net Income high stood at $8.0 million for FY2015, and its period low was -$53.2 million during FY2018.
  • For the 3-year period, EyePoint Pharmaceuticals' Consolidated Net Income averaged around -$31.1 million, with its median value being -$21.5 million (2016).
  • As far as peak fluctuations go, EyePoint Pharmaceuticals' Consolidated Net Income spiked by 160.08% in 2015, and later plummeted by 368.53% in 2016.
  • Yearly analysis of 5 years shows EyePoint Pharmaceuticals' Consolidated Net Income stood at -$13.4 million in 2014, then soared by 160.08% to $8.0 million in 2015, then crashed by 368.53% to -$21.5 million in 2016, then grew by 14.21% to -$18.5 million in 2017, then slumped by 187.64% to -$53.2 million in 2018.